Blood-brain barrier disruption induces in vivo degeneration of nigral dopaminergic neurons

被引:110
作者
Rite, Inmaculada [1 ]
Machado, Alberto [1 ]
Cano, Josefina [1 ]
Venero, Jose L. [1 ]
机构
[1] Univ Seville, Fac Farm, Dept Bioquim Bromatol Toxicol & Med Legal, E-41012 Seville, Spain
关键词
apoptosis; microglia activation; Parkinson's disease; tyrosine hydroxylase loss; vascular endothelial growth factor; ventral mesencephalon;
D O I
10.1111/j.1471-4159.2007.04567.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have evaluated the possibility that changes in the vascular system may constitute a contributing factor for the death of nigral dopaminergic neurons in Parkinson's disease. Thus, we have employed intranigral injections of vascular endothelial growth factor (VEGF), the most potent inducer of blood-brain barrier (BBB) permeability. A single dose of 1 mu g of VEGF, chosen from a dose-response study, highly disrupted the BBB in the ventral mesencephalon in a time-dependent manner. A strong regional correlation between BBB disruption and loss of tyrosine hydroxylase-positive neurons was evident. Moreover, Fluoro-Jade B labelling showed the presence of dying neurons in the substantia nigra in response to VEGF injection. High number of TUNEL-positive nuclei was observed in this area along with activation of caspase 3 within nigral dopaminergic neurons. Analysis of the glial population demonstrated a strong inflammatory response and activation of astroglia in response to BBB disruption. We conclude that disruption of the BBB may be a causative factor for degeneration of nigral dopaminergic neurons.
引用
收藏
页码:1567 / 1582
页数:16
相关论文
共 68 条
  • [1] Ischaemic brain oedema
    Ayata, C
    Ropper, AH
    [J]. JOURNAL OF CLINICAL NEUROSCIENCE, 2002, 9 (02) : 113 - 124
  • [2] Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease
    Banati, RB
    Daniel, SE
    Blunt, SB
    [J]. MOVEMENT DISORDERS, 1998, 13 (02) : 221 - 227
  • [3] Changes in vascularization in substantia nigra pars compacta of monkeys rendered parkinsonian
    Barcia, C
    Bautista, V
    Sánchez-Bahillo, A
    Fernández-Villalba, E
    Faucheux, B
    Poza, MPY
    Barreiro, AF
    Hirsch, EC
    Herrero, MT
    [J]. JOURNAL OF NEURAL TRANSMISSION, 2005, 112 (09) : 1237 - 1248
  • [4] Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients
    BlumDegen, D
    Muller, T
    Kuhn, W
    Gerlach, M
    Przuntek, H
    Riederer, P
    [J]. NEUROSCIENCE LETTERS, 1995, 202 (1-2) : 17 - 20
  • [5] Head trauma preceding PD - A case-control study
    Bower, JH
    Maraganore, DM
    Peterson, BJ
    McDonnell, SK
    Ahlskog, JE
    Rocca, WA
    [J]. NEUROLOGY, 2003, 60 (10) : 1610 - 1615
  • [6] Vascular endothelial growth factor and the nervous system
    Brockington, A
    Lewis, C
    Wharton, S
    Shaw, PJ
    [J]. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2004, 30 (05) : 427 - 446
  • [7] Thrombin induces in vivo degeneration of nigral dopaminergic neurones along with the activation of microglia
    Carreño-Müller, E
    Herrera, AJ
    de Pablos, RM
    Tomás-Camardiel, M
    Venero, JL
    Cano, J
    Machado, A
    [J]. JOURNAL OF NEUROCHEMISTRY, 2003, 84 (05) : 1201 - 1214
  • [8] 6-Hydroxydopamine-induced alterations in blood-brain barrier permeability
    Carvey, PM
    Zhao, CH
    Hendey, B
    Lum, H
    Trachtenberg, J
    Desai, BS
    Snyder, J
    Zhu, YG
    Ling, ZD
    [J]. EUROPEAN JOURNAL OF NEUROSCIENCE, 2005, 22 (05) : 1158 - 1168
  • [9] An evaluation of the role of mitochondria in neurodegenerative diseases: mitochondrial mutations and oxidative pathology, protective nuclear responses, and cell death in neurodegeneration
    Cassarino, DS
    Bennett, JP
    [J]. BRAIN RESEARCH REVIEWS, 1999, 29 (01) : 1 - 25
  • [10] Castaño A, 1998, J NEUROCHEM, V70, P1584